Andrew Rappaport
CIK: 0001162157
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
Olema Pharmaceuticals, Inc.
Discretionary Trading P&L
Holdings
Transaction History (4 total)
- Jun 18, 2026OLMA
Olema Pharmaceuticals, Inc.
Award(A)DirectStock Option (right to buy)
29.5K shares- - Nov 25, 2025OLMA
Olema Pharmaceuticals, Inc.
Gift(G)Direct35.9K shares- - Nov 21, 2025OLMA
Olema Pharmaceuticals, Inc.
Exercise(M)Direct35.9K shares at avg. $0.39$14K - Jun 11, 2025OLMA
Olema Pharmaceuticals, Inc.
Award(A)DirectStock Option (right to buy)
24.2K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jun 18, 2026 | OLMA Olema Pharmaceuticals, Inc. | Award(A) Stock Option (right to buy) | 29,500 | - | - | Direct |
| Nov 25, 2025 | OLMA Olema Pharmaceuticals, Inc. | Gift(G) | 35,868 | - | - | Direct |
| Nov 21, 2025 | OLMA Olema Pharmaceuticals, Inc. | Exercise(M) | 35,868 | $0.39 | $13,989 | Direct |
| Jun 11, 2025 | OLMA Olema Pharmaceuticals, Inc. | Award(A) Stock Option (right to buy) | 24,150 | - | - | Direct |
1-4 of 4 transactions
About RAPPAPORT ANDREW
RAPPAPORT ANDREW (SEC CIK 0001162157) files insider reports with the SEC as Director of Olema Pharmaceuticals, Inc. (OLMA).
Signal8 holds 3 ownership filings by RAPPAPORT ANDREW, all Form 4s, filed between Jun 13, 2025 and Jun 23, 2026. Those filings report 4 transactions, from Jun 11, 2025 to Jun 18, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on RAPPAPORT ANDREW's filings is in SAN FRANCISCO, CA.
Recent filings by RAPPAPORT ANDREW
Other insiders filing for Olema Pharmaceuticals, Inc. (OLMA)
- O'Byrne Jason, CHIEF FINANCIAL OFFICER
- Harmon Cyrus, Director
- BVF PARTNERS L P/IL, Director
- BUTITTA CYNTHIA M, Director
- Garland J. Scott, Director
- Hrustanovic Gorjan, Director